| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |